We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GIL:TSXGildan Activewear Inc. Analysis

Data as of 2026-09-01 - not real-time

CA$72.29

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

At CAD 72.29, Gildan Activewear Inc. shows no decisive moving-average alignment, leaving the trend neutral. The last 30 days have lost 4.6%. Momentum indicators put RSI at 36.7 (approaching oversold) with MACD reading bearish. Price has been bracketed by support at CAD 71.83 and resistance at CAD 82.85.
Valuation screens as fair, on a P/E of 40.4 with no clean sector comparison available. Analyst price targets sit 43.0% above the current price. Revenue is growing at 72.3% on a 1.3% profit margin. The 1.90% dividend yield looks stretched against payout coverage.
On a 1-10 scale the risk profile lands at 5 — moderate. With 30-day volatility of 35.8%, a beta of 1.17 and a maximum drawdown of 29.4%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
This one splits by horizon — sell in the near term, hold further out, at 3/10 long-term conviction.

Top Market Events

all amounts are in U.S. dollars except where otherwise indicated 1 Please refer to "Non-GAAP financial measures and...Gildan crushed earnings estimates with adjusted EPS of $1.MONTREAL, July 15, 2026 GLOBE NEWSWIRE -- Gildan Activewear Inc.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 5/10

Key Factors

  • Trading below the 200-day average of 81.97
  • MACD momentum is negative
  • Maximum drawdown of 29.4%

Medium Term

1–3 years
Neutral
Model confidence: 4/10

Key Factors

  • Dividend yield of 1.90% looks stretched against payout coverage
  • Trading below the 200-day average of 81.97
  • Analyst targets imply +43.0% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 3/10

Key Factors

  • Dividend yield of 1.90% looks stretched against payout coverage
  • Analyst targets imply +43.0% versus the current price
  • Revenue growth of +72.3%

Key Metrics & Analysis

Financial Health

Revenue Growth72.30%
Profit Margin1.28%
P/E Ratio40.4
ROE8.68%
ROA8.48%
Debt/Equity147.65
P/B Ratio2.9
Op. Cash FlowCA$628.3M
Free Cash FlowCA$-807118016

Technical Analysis

TrendNeutral
RSI36.7
SupportCA$71.83
ResistanceCA$82.85
MA 20CA$77.82
MA 50CA$75.39
MA 200CA$81.97
MACDBearish
VolumeStable
Fear & Greed Index93.16

Valuation

Fair ValueCA$57.90
Target PriceCA$103.34
Upside/Downside42.95%
GradeFair
TypeGrowth
Dividend Yield1.90%

Risk Assessment

Beta1.17
Volatility35.84%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.